Compugen Ltd Share Price

NASDAQ: CGEN

Small Cap

$1.35

-0.03

(-2.17%)

as on September 18, 2025 at 1:29 am IST

$₹

Compugen Ltd Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.34
Day's Price Range
$1.38
$1.35
0.74%
Downside
2.22%
Upside
52 Week's Low
52 Week's High
$1.13
52-Week Price Range
$2.66
$1.35
16.30%
Downside
97.04%
Upside

Compugen Ltd share price movements today

Previous Close: $1.38
Open: $1.38
Volume: 354.8K
Day's Low - High: $1.34 - $1.38
52 Week Low - High: $1.13 - $2.66

Compugen Ltd Historical Returns

1 Month Return: -3.5 %
3 Month Return: -16.36 %
1 Year Return: -25.81 %
3 Year Return: + 38 %
5 Year Return: -92.4 %

Compugen Ltd Stock Fundamentals & Key Indicators

Check Compugen Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$129.1M

EPS (TTM)

-0.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.4

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

-19.3M

Revenue (TTM)

22.1M

Profit Margin

-87.45%

Return On Equity TTM

41052600.00%

Compugen Ltd Stock Valuation

Track how Compugen Ltd P/E has moved over time to understand its valuation trends.

Compugen Ltd in the last 5 years

Overview
Trends

Lowest (75.44x)

September 30, 2024

Today (-5.40x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Highest (75.44x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -5.40x

Compugen Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Compugen Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Compugen Ltd	BUY	$129.1M	-92.4%	-5.4	-87.45%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Compugen Ltd Stock including INR - Dollar returns

The Compugen Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Compugen Ltd investment value today

Current value as on today

₹77,179

Returns

₹22,821

(-22.82%)

Returns from Compugen Ltd Stock

₹27,419 (-27.42%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Compugen Ltd Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Compugen Ltd. Average target price of $6.25

Compugen Ltd Share Price Target

Get share price movements and forecasts by analysts on Compugen Ltd.

What analysts predicted

78.4%UPSIDE

Target Price

$6.25

Current Price

$1.35

Analyzed by

9 Analysts

Target

$6.25

Compugen Ltd target price $6.25, a slight upside of 78.4% compared to current price of $1.35. According to 9 analysts rating.

Compugen Ltd Stock's Interest Amongst Investors

Search interest for Compugen Ltd Stock has increased by 633% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:633% versus previous 30 day period

Compugen Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	33	2	6	17	1	2	1
Gross Profit	-	-	-	31	0	5	13	0	0	0
Operating Income	-10	-10	-10	17	-8	-3	4	-7	-8	-8
EBITDA	-10	-10	-10	17	-8	-3	4	-7	-8	-7
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-9	-9	-9	18	-7	-2	5	-6	-7	-7
Income Tax Expense	0	0	0	9	0	0	4	0	0	0
Net Income	-9	-9	-9	9	-7	-2	1	-6	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	29.03%	-283.98%	-31.68%	7.45%	-415.84%	-314.40%	-584.09%

Compugen Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	9	0	-	17	-	2	6	7	33	27
Gross Profit	7	0	-1	16	0	1	5	6	31	19
Operating Income	-20	-32	-37	-23	-28	-31	-35	-35	-12	-14
EBITDA	-19	-31	-35	-21	-27	-30	-34	-34	-12	-14
Interest Expense	0	0	0	0	1	1	0	0	0	0
Depreciation	-	-	1	1	0	0	0	0	0	0
Income Before Tax	-19	-31	-37	-22	-28	-29	-34	-33	-9	-9
Income Tax Expense	0	0	0	-1	0	-2	-1	0	8	4
Net Income	-20	-31	-37	-22	-27	-27	-32	-33	-18	-14
Net Profit Margin	-217.34%	-4425.00%	0.00%	-126.96%	0.00%	-1363.00%	-547.88%	-449.25%	-56.05%	-51.07%

Compugen Ltd Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-9	-9	9	-7	-2	1	-6	-7	-7
Operating Cash Flow	-	-	-	-	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-	-	-	-	-
Change in Cash	-56	30	-	-	-	-	-	-	-

Compugen Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-31	-37	-22	-27	-29	-34	-33	-18	-14
Operating Cash Flow	-19	-30	-13	-27	-28	-22	-34	-35	49
Investing Cash Flow	16	46	-35	5	-82	6	37	35	-46
Financing Cash Flow	2	0	28	25	108	16	0	3	0
Change in Cash	-1	15	-20	3	-2	0	2	2	3

Insights on Compugen Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 78.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 93.9%
NEGATIVE IMPACT
Price Dip
In the last 3 months, CGEN stock has moved down by -16.4%

About Compugen Ltd

compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. the company utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its pipeline program. the company's business model includes collaborations covering the further development and commercialization of product candidates at various stages from its pipeline program and various forms of research and discovery agreements, in both cases providing compugen with potential milestone payments and royalties on product sales or other forms of revenue sharing. compugen’s wholly-owned u.s. subsidiary located in south san francisco is developing monoclonal antib

Organisation	Compugen Ltd
Headquarters	Azrieli Center, Holon, Israel, 5885849
Industry	Health Technology
CEO	Dr. Anat Cohen-Dayag Ph.D.
E-voting on shares	Click here to vote

Key Management of Compugen Ltd

Name	Title
Mr. David Silberman CPA	Chief Financial Officer
Mr. Eran Ben Dor	General Counsel & Corporate Secretary
Ms. Dorit Amitay	Vice President of Human Resources
Dr. Anat Cohen-Dayag Ph.D.	CEO, President & Director
Dr. Zurit Levine Ph.D.	Senior Vice President of Strategic Collaborations
Ms. Michelle Mahler M.D.	Chief Medical Officer
Ms. Yvonne Naughton	Head of Investor Relations & Corporate Communications
Dr. Yaron Turpaz M.B.A., Ph.D.	Senior VP & Senior Advisor of Data and Informatics Solutions
Dr. Eran Ophir Ph.D.	Chief Scientific Officer
Dr. Pierre Ferre Ph.D.	Senior VP of Preclinical Development & Corporate Operations

FAQs

What is Compugen Ltd share price today?

Compugen Ltd share price today is $1.35 as on September 18, 2025 at 1:29 am IST at the close of the market. Compugen Ltd share today touched a day high of $1.38 and a low of $1.34.

What is the 52 week high and 52 week low for Compugen Ltd share?

Compugen Ltd share touched a 52 week high of $2.66 on February 10, 2025 and a 52 week low of $1.13 on April 9, 2025. Compugen Ltd stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.35,which is 49.25% down from its 52 week high and 19.47% up from its 52 week low.

What is Compugen Ltd's market capitalisation today?

Compugen Ltd market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Compugen Ltd Stock (CGEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Compugen Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Compugen Ltd Shares that will get you 1.1111 shares as per Compugen Ltd share price of $1.35 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Compugen Ltd Stock (CGEN) from India?

Indian investors can start investing in Compugen Ltd (CGEN) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 5:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Compugen Ltd stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 5:42 am IST). Based on Compugen Ltd share’s latest price of $1.35 as on September 18, 2025 at 1:29 am IST, you will get 7.4074 shares of Compugen Ltd. Learn more about fractional shares .

What are the returns that Compugen Ltd has given to Indian investors in the last 5 years?

Compugen Ltd stock has given -92.4% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?